Abstract
Aim To describe the pattern of the prevalence of mental health problems during the first year of the COVID-19 pandemic and examine the impact of containment measures on these trends. Methods We identified articles published until 30 August 2021 that reported the prevalence of mental health problems in the general population at two or more time points. A crowd of 114 reviewers extracted data on prevalence, study and participant characteristics. We collected information on the number of days since the first SARS-CoV-2 infection in the study country, the stringency of containment measures and the number of cases and deaths. We synthesised changes in prevalence during the pandemic using a random-effects model. We used dose-response meta-analysis to evaluate the trajectory of the changes in mental health problems. Results We included 41 studies for 7 mental health conditions. The average odds of symptoms increased during the pandemic (mean OR ranging from 1.23 to 2.08). Heterogeneity was very large and could not be explained by differences in participants or study characteristics. Average odds of psychological distress, depression and anxiety increased during the first 2 months of the pandemic, with increased stringency of the measures, reported infections and deaths. The confidence in the evidence was low to very low. Conclusions We observed an initial increase in the average risk of psychological distress, depression-related and anxiety-related problems during the first 2 months of the pandemic. However, large heterogeneity suggests that different populations had different responses to the challenges imposed by the pandemic.
| Original language | English |
|---|---|
| Article number | e301018 |
| Pages (from-to) | 1-8 |
| Number of pages | 8 |
| Journal | BMJ Mental Health |
| Volume | 27 |
| Issue number | 1 |
| Early online date | 13 Jun 2024 |
| DOIs | |
| Publication status | Published - 2024 |
Bibliographical note
Publisher Copyright:© 2024 BMJ Publishing Group. All rights reserved.
Funding
TT, NP, AH, and GS received funding from the Swiss National Science Foundation (Nr 198418). AC is supported by the National Institute for Health Research (NIHR) Oxford Cognitive Health Clinical Research Facility, by an NIHR Research Professorship (grant RP-2017- 08- ST2- 006), by the NIHR Oxford and Thames Valley Applied Research Collaboration and by the NIHR Oxford Health Biomedical Research Centre (grant NIHR203316). The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the UK Department of Health.IW was supported by the Medical Research Council Programme MC_UU_00004/06. CK is a UK Academy of Medical Sciences Newton Advanced Fellow and a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) researcher. \"ME and ADH were supported by the Swiss National Science Foundation (grants 32FP30-189498 and 193381). From The MHCOVID Crowd Investigators: EO acknowledges research funding from NIHR Applied Research Collaboration Oxford Thames Valley, NIHR Oxford Cognitive Health Clinical Research Facility, NIHR Oxford Health Biomedical Research Centre (BRC-1215- 20005) and Brasenose College Senior Hulme Scholarship. GA was supported by a grant from the Department of Health Planning, Evaluation and Knowledge Management, Government of Navarra, Spain (Ref. 0011-3638- 2020- 000010); the Ramon y Cajal grant RYC2020 ]030744 ]I funded by MCIN/AEI/ 10.13039/501100011033 and 'ESF Investing in your future'; and by the 2022-2023 Institute for Culture and Society (ICS) challenge on 'Youth, relationships and psychological well-being' of the University of Navarra. TT, NP, AH, and GS received funding from the Swiss National Science Foundation (Nr 198418). AC is supported by the National Institute for Health Research (NIHR) Oxford Cognitive Health Clinical Research Facility, by an NIHR Research Professorship (grant RP-2017-08-ST2-006), by the NIHR Oxford and Thames Valley Applied Research Collaboration and by the NIHR Oxford Health Biomedical Research Centre (grant NIHR203316). The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the UK Department of Health.IW was supported by the Medical Research Council Programme MC_UU_00004/06. CK is a UK Academy of Medical Sciences Newton Advanced Fellow and a Conselho Nacional de Desenvolvimento Cient\u00EDfico e Tecnol\u00F3gico (CNPq, Brazil) researcher. \u201CME and ADH were supported by the Swiss National Science Foundation (grants 32FP30-189498 and 193381). From The MHCOVID Crowd Investigators: EO acknowledges research funding from NIHR Applied Research Collaboration Oxford Thames Valley, NIHR Oxford Cognitive Health Clinical Research Facility, NIHR Oxford Health Biomedical Research Centre (BRC-1215-20005) and Brasenose College Senior Hulme Scholarship. GA was supported by a grant from the Department of Health Planning, Evaluation and Knowledge Management, Government of Navarra, Spain (Ref. 0011-3638-2020-000010); the Ram\u00F3n y Cajal grant RYC2020\u2010030744\u2010I funded by MCIN/AEI/ 10.13039/501100011033 and \u2018ESF Investing in your future\u2019; and by the 2022-2023 Institute for Culture and Society (ICS) challenge on \u2018Youth, relationships and psychological well-being\u2019 of the University of Navarra.
| Funders | Funder number |
|---|---|
| Ministerio de Ciencia e Innovación | |
| 2022-2023 Institute for Culture and Society | |
| European Social Fund Plus | |
| Intensive Care Society | |
| Agencia Estatal de Investigación | |
| Universidad de Navarra | |
| National Health Service | MC_UU_00004/06 |
| NIHR Oxford Biomedical Research Centre | NIHR203316 |
| Ramon y Cajal | 030744, RYC2020 |
| National Institute for Health and Care Research Applied Research Collaboration Oxford and Thames Valley | BRC-1215-20005 |
| Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung | 198418, Nr 198418, 193381, 189498 |
| Conselho Nacional de Desenvolvimento Científico e Tecnológico | 32FP30-189498 |
| Department of Health Planning | 0011-3638-2020-000010 |
| National Institute for Health and Care Research | RP-2017-08-ST2-006 |
Keywords
- COVID-19
- Data Interpretation, Statistical
- Depression